CXCL8 and head and neck squamous cell carcinoma: To evaluate this hypothesis, we demonstrated that galectin-7 treatment significantly induced CXCL8 expression in various CAF cells (CAF30, CAF57, CAF58, and CAF70) as well as HNSCC cells (SCCQLL1 and SNU1066) (Fig. 5f).